Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ACADEMIA
ACADEMIA
- Low-Dose Aspirin Might Cut Dementia Risks in Diabetes Women: Researchers
December 5, 2019
- National Neurology Center Starts Investigator-Led Trial for DMD Drug Targeting Exon 44
November 8, 2019
- Academic Society Calls for Caution in Using Xofluza in Patients Under Age 12
October 28, 2019
- Nephrology Society Poised to Compile Drug Development Guidelines for Early-Stage Kidney Disease
October 18, 2019
- Cancer Institute Hospital Opens Development Center to Resolve Challenges of Immunotherapy with Pharma Companies
October 18, 2019
- Research Group at Tokyo Medical and Dental Univ. Succeeds in Producing Multi-Organ Structure from iPS Cells
September 27, 2019
- Drug Makers Evaluating MSLs Using Both Qualitative, Quantitative Criteria: JAPhMed Survey
September 25, 2019
- High Response Rate in Brain Metastasis Patients Earned High Marks for Rozlytrek’s Sakigake Status: Oncologist
September 6, 2019
- Anticoagulant Monotherapy Does Not Increase CV Events in Coronary Artery Disease Patients with AF: Cardiovascular Center
September 6, 2019
- 4 Scientific Societies Submit Proposal to Health Minister to Ensure Stable Antibiotic Supplies
September 4, 2019
- Investigator-Led Clinical Trial to Get Underway for Next-Gen Oncolytic Virus
August 28, 2019
- 80% of Diabetes Patients on Antihypertensives Use ACE Inhibitors/ARBs: MHLW Study
August 19, 2019
- 5-Year Cancer Survival Rates in Japan Stand at 66.1%: NCC
August 9, 2019
- NCC Hospital Crafting Scheme to Offer Off-Label Meds after Genomic Profiling
July 23, 2019
- Submission of Oncolytic Virus G47Δ Lagging as Team Still Preps for Manufacturing
July 22, 2019
- After Listing Delayed, Collategene Expected to Reach Market by Year-End: AnGes Founder
July 22, 2019
- Japanese Data More Positive for Keytruda’s Frontline Use in Gastric Cancer
July 22, 2019
- Keytruda Shows Promise in Japanese HCC Patients despite Global Miss
July 22, 2019
- Keytruda Slashes Death Risk by 78% in Japanese Head and Neck Cancer Patients
July 19, 2019
- New Pancreatic Cancer Guidelines Recommend FOLFIRINOX as 1st-Line Therapy
July 19, 2019
ページ
Japan’s health and finance ministers agreed late last year to go ahead with an “off-year” drug price revision in FY2027,…
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…